Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. (2013)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2013.219
PubMed Identifier: 23860450
Publication URI: http://europepmc.org/abstract/MED/23860450
Type: Journal Article/Review
Volume: 27
Parent Publication: Leukemia
Issue: 10
ISSN: 0887-6924